Target intelligence / Profile preview

RNA, U2 small nuclear 11, pseudogene (RNU2-11P)

Target: RNU2-11P
Molecular classification: Other

Overview

RNA, U2 small nuclear 11, pseudogene (RNU2-11P) is a human gene classified as a pseudogene, derived from the U2 small nuclear RNA (snRNA) family involved in the splicing of precursor mRNA. As a pseudogene, RNU2-11P generally does not produce a functional RNA or protein product and is not considered an active biological or therapeutic target. There is no evidence that RNU2-11P is associated with diseases, used as a biomarker, or interacts with drugs[2][3][4].

Other names: RNU2-11P

Biological functions

Other

Beyond the preview

Go deeper on RNA, U2 small nuclear 11, pseudogene (RNU2-11P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 11, pseudogene (RNU2-11P).

Explore the full profile